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Onosma griffithii was screened for possible pharmacological activities. The crude methanolic extract 
(MeOH) and its fractions demonstrated parasiticidal activity (IC 50 (µg/ml ± S.D) = 31.03 ± 0.23) against 
Leishmania major. Based on the IC 50 values, the potency of the standard drug (Pentamidine) and test 
fractions were of the order as: Pentamidine > crude extract > n-hexane fraction > ethyl acetate (ETOAc) 
fraction > chloroform fraction (CHCl3) fraction > n-butanol (BUOH) fraction > aqueous fraction. Similarly 
moderate antifungal activity was displayed by the crude methanolic extract against Aspergillus flavus 
and Fusarium solani. Against the Staphylococcus aureus, the aqueous fraction demonstrated moderate 
antibacterial activity. 
 





The family Boraginaceae consists of about 100 genera 
and 2000 species distributed in temperate, especially in 
Mediterranean and tropical regions (Ali and Nasir, 1983). 
Onosma is an important genus of the family as extracts of 
some species of Onosma, except Onosma hispidum, 
have been used as antioxidant, antibacterial, antiviral and 
anti-inflammatory agents (Tosun et al., 2008). Traditional-
ly, Onosma is used as stimulant in rheumatism, bladder 
pain, kidney irritation and palpitation of heart (Ahmed, 
2004). Hispidone, a new flavanone has been isolated 
from O. hispidum that have cholinesterase inhibitory acti-
vity (Ahmad et al., 2003). O. hispida is also used as colo-
rant (Shahina, 2005). Similarly, anticancer activity of 
Onosma limitaneum (Ahmad et al., 2005), antioxidant 
and antimicrobial activities of Onosma argenatum have 
been reported. It has been suggested that the roots of 
some plant of Boraginaceae contain naphthaquinone 
derivatives. Shikanins and alkanins do exist in the 
Onosma species (Ufuk et al., 2004).  
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wound healing and burns with well documented anti-
oxidant and antimicrobial activity (Sezik et al., 1997; 
Ozgen et al., 2003). This suggests that this genus is very 
potent from pharmacological activities point of view. 
Hence we carried out experiments to screen Onosma 
griffithii specie for possible pharmacological activities. 
 
 
MATERIALS AND METHODS 
 
Plant material 
   
Aerial parts of the plant, O. griffithii (Boraginaceae), were collected 
from the nearby hills of Campus I of University of Malakand, in 
June-July 2005 and identified by Professor Dr. Jahandar Shah, 
Plant Taxonomist, University of Malakand, Chakdara Dir N.W.F.P 
Pakistan. A voucher specimen (OG-05) has been deposited in the 





The shade dried plant material was crushed into small pieces and 
finally pulverized into fine powder. The plant material (7 kg) was 
soaked in methanol with occasional shaking, at room temperature. 
After 15 days, the methanol soluble materials were filtered off. The 
filtrate was concentrated under vacuum at  low  temperature  (below  




Table 1. Antileishmanial activities of crude methanolic extract and fractions of Onosma griffithii against the 
susceptible strains of Leishmania major promastigotes (Pakistani isolates). IC50 values in µg/ml ± S.D obtained from 
three separate experiments are shown.  
 
Control 
Extract / Fraction / 
standard* Negative Control 
(% Survivors) 




(µg/ml ± S.D) 
Mean relative 
index (IC50 Sample 
/ IC50 Standard) 
Pentamidine* 100% 100% 2.5 ±  0.09 1 
Crude methanolic extract 100% 100% 31.03 ± 0.23 12.41 
n-Hexane 100% 100% 31.36 ± 0.34 12.54 
Chloroform 100% 100% 42.60 ±0.465 16.24 
Ethyl acetate 100% 100% 38.39 ± 0.37 15.32 
n-Butanol 100% 100% 41.87 ± 0.39 16.748 










The crude methanolic extract (150 g) was suspended in distilled 
water (400 ml) and sequentially partitioned with n-hexane (3 x 350 
ml), chloroform (3 x 350 mL), ethyl acetate (3 x 350 ml) and n-buta-
nol (3 x 350 ml) to yield n- hexane (30 g), chloroform (20 g), ethyl 
acetate (2g), n-butanol (2 g) and aqueous (65 g) fractions, respec-






All the experiments were performed in triplicate. Standard devia-
tions and IC50 values of compounds possessing antileishmanial 
activity were calculated by Software Ezfit 5.03 Perella Scientific. P 
values of 0.05 or less was considered significant using student’s “t” 





The antileishmanial activity was performed according to the proce-
dure of Rehman et al. (1991) described as follows: 
 
 
Parasite culture  
 
Leishmania major parasite’s Promastigotes were grown in bulk, 
early in modified NNN biphasic medium, using normal physiological 
saline. Then the Promastigotes were cultured with RPMI 1640 me-
dium supplemented with 10% heat inactivated fetal bovine serum 
(FBS). The parasites, at log phase, were centrifuged at 2000 rpm 
for 10 min and washed three times with saline at same speed and 
time. Finally the parasites were diluted with fresh culture medium to 
give a final density of 106 cells/ml. 
In a 96 -well micro titer plate, 180 µl of medium was added in dif-
ferent wells. 20 µl of the experimental compound was added in 
medium and serially diluted so that the minimum concentration of 
compound was one 1 µg/ml. 100 µl of parasite culture (final density 
of 106 cells/ml) was added in all wells. 2 rows were left one for 
negative and other for positive control. Negative controls received 
the medium while the positive control received Pentamidine as 
standard antileishmanial compound. The plate was incubated at 21 
- 22°C for 72 h. The culture was examined microscopically for cell 
viability by counting the number of motile cells on an improved 
neubauer counting chamber and IC50 values of compounds pos-
sessing antileishmanial activity were calculated by Software Ezfit 
5.03 Perella Scientific. IC50 values of different fractions against the 
test pathogen are mentioned in Table 1. 
 
 
Antifungal activity  
 
Similarly antifungal activity was evaluated by agar tube dilution 
method as per our reported procedure (Bashir et al., 2007). Des-
cribing the procedure, the test samples in the concentration of 24 
mg/ml were dissolved in the sterile (autoclaved) dimethyl sulfoxide 
(DMSO, Merck), which served as stock solution. Sabouraud 
Dextrose Agar (SDA, Sigma-Aldrich, Germany) was prepared by 
mixing 32.5 g sabouraud, 4% glucose agar and 4.0 g of agar-agar 
in 500 ml distilled water and the mixture was mixed thoroughly with 
magnetic stirrer. Then 4 ml amount was dispensed into screw cap 
tubes, which were autoclaved at 120ºC for 15 min and then cooled 
to 15ºC. The non-solidified SDA media was mixed with stock solu-
tion (66.6 µl) giving the final concentration of 400 µg of the extract 
per ml of SDA. Tubes were then allowed to solidify in the slanted 
position at room temperature. Each tube was inoculated with a 
piece (4 mm diameter) of inoculums removed from a seven days 
old culture of fungi for non-mycelial growth; an agar surface streak 
of Aspergillus flavus and Fusarium solani was employed. Other 
media supplemented with dimethyl sulfoxide (DMSO) and standard 
antifungal drugs served as negative and positive control respec-
tively (Figure 1). Inhibition of fungal growth was observed after 7 
days of incubation at 28 ± 1ºC. Humidity (40 - 50%) was controlled 





The crude extract along with fractions was screened against 
various human pathogens including Escherichia coli, Bacillus 
subtilis, Shigella flexenari, Staphylococcus aureus and Salmonella 
typhi as per our reported procedure (Bashir et al., 2007). In this 
method, 10 ml aliquots of nutrients broth (Sigma-Aldrich, Germany) 
was inoculated with the test organism and incubated at 37ºC for 24 
h. 
Using a sterile pipette, 0.6 ml of the broth culture of the test 
organism was added to 60 ml of molten agar, which had been 
cooled to 45ºC, mixed well and poured into a sterile petri dish (for 
the 9 cm petri dish, 0.2 ml of the culture was added to 20 ml of 
agar). Duplicate plates of each organism were  prepared. The  agar  






Figure 1. Antifungal activities of crude extract and fractions of 
Onosma griffithii against Aspergillus flavus and Fusarium 
solani using Amphotericin B (20 µg/ml) and Miconazole (98.4 




was allowed to set and harden and the required numbers of wells 
were dug in the medium with the help of a sterile metallic cork borer 
ensuring proper distribution of the wells in the periphery and one in 
the center. Agar plugs were removed. Stock solutions of the test 
samples in the concentration of 1 mg/ml were prepared in the 
sterile dimethyl sulfoxide (DMSO) and 100 and 200 µl of each 
dilution was added in their respective wells. The control well re-
ceived only 100 and 200 µl of DMSO. Imipenem was used as 
standard drug. The plates were left at room temperature for 2 h to 
allow diffusion of the samples then incubated face upwards at 37ºC 








Leishmaniasis particularly cutaneous leishmaniasis is a 
parasitic disease with diverse clinical manifestations that 
depends on both infecting species of Leishmania and the 
immune response of the host (WHO, 1984). The results 
of the crude methanolic extract and its fractions are sum-
marized in Table 1. 
The lower the IC50 value of a drug against a particular 
pathogen, the more will be its potency and vice versa. 
Based on the IC50 values (Table 1), the crude methanolic 
extract and its fractions showed statistically significant (P 
< 0.05) antileishmanial activities against the L. major, 
Pakistani isolates. In comparison with the Pentamidine as 





its various fractions demonstrated the order of potency 
as: Pentamidine > crude extract > n-hexane fraction > 
ethyl acetate > chloroform fraction > n-butanol > aqueous 
fraction. Cutaneous leishmaniasis being a challenge and 
threat to Pakistani society as its incidence increases day 
by day. There were 350 patients in 1995 - 1997, 1210 
patients in 1996-2001 and 1640 patients reported in 2008 
in Pakistan (Bhutto et al., 2008). Therapy results of al-
ready existing topical preparation of paromomycin and 
gentamicin combination are not so much satisfactory be-
cause of 50% relapse and resistance (Grogl et al., 1999; 
El-On et al., 1991). Therefore, search for new antile-
ishmanial drugs is necessary.  
Very few medicinal plants have been reported for their 
antileishmanial activities (Kvist et al., 2006), hence the 
plant specie could be a potential target for activity guided 
isolation of bioactive compounds as the crude methanolic 
extract and its fractions are very potent because of their 





The crude methanolic extract of O. griffithii displayed 
moderate antifungal activity against Aspergillus flavus 
(55%) and Fusarium solani (40%). Whereas, the chloro-
form fraction showed good antifungal activity against A. 
flavus (59%) and Fusarium solani (60%). While rest of 
the fractions showed no antifungal activity against the 
stated fungal strains (Figure 1). This confirms the folkloric 
uses of the species of the onosma genus in the treatment 





Crude methanolic extract and all fractions of O. griffithii 
were screened for antibacterial activity. The results are 
summarized in Figure 2. It is evident that against S. flex-
enari the fractionated extracts showed antibacterial 
activity of the order as CHCl3 Fraction (33.3%) > EtOAc 
Fraction = Aqueous Fraction (30.55%) > n-hexane 
Fraction (27.77%). Against B. substillus n-hexane Frac-
tion and CHCl3 Fraction showed 29.72 and 33.42 % 
antibacterial activity respectively. Against the S. aureus, 
the aqueous fraction demonstrated moderate anti-
bacterial activity (42.3%) and the EtOAc fraction showed 
38.46% antibacterial activity. The rest of the fractions 





O. griffithii has potent antileishmanial and moderate anti-
fungal and antibacterial activities that strongly encourage 





















































B. subitilis S. flexenari S. aureus
 
 







The author wants to thank the Sponsor Higher Education 
Commission, Islamabad for Research Grant No: 1-





Ahmad I, Anis I, Malik A, Nawaz SA, Choudhary MI (2003). 
Cholinesterase Inhibitory Constituents from Onosma hispida Chem. 
Pharm. Bull. 51(4): 412-414. 
Ahmad VU, Kousar F, Khan A, Zubair M, Iqbal S, Tareen RB (2005). A 
New Ketone and a known anticancer triterpenoid from the leaves of 
Onosma  limitaneum, Helv. Chim. Acta. 88(2): 309-311. 
Ali SI, Nasir YJ (1983). Onosma griffithii Vatke (Boraginaceae) (Eds.) In: 
Flora of Pakistan vol. 191, Shamim Printing Press Karachi p.103. 
Bashir A, Shah SMH, Bashir S, Nisar M, Chaudry MI (2007). 
Antibacterial and antifungal activities of Andrachne cordifolia muell. J. 

























Bhutto AM, Soomro FR, Katakura K (2008). Leishmaniasis in Sindh, 
Pakistan: Outbreak and review of literature. J. Pak. Assoc. Dermatol. 
18: 212-219. 
El-On J, Sulitzeanu A, Shnur LF (1991). Leishmania major: resistance 
of promastigotes to paromomycin, and susceptibility of amastigotes 
to paromomycin- methylbenzethonium chloride ointment. Ann. Trop. 
Med. Parasitol. 85(3): 323-328. 
Grogl M, Schuster BG, Ellis WY, Berman JD (1999). Successful topical 
treatment of murine cutaneous leishmaniasis with a combination of 
paromomycin (Aminosidine) and gentamicin. J. Parasitol. 85(2): 354-
359. 
Kvist LP, Christensen SB, Rasmussen HB, Mejia K, Gonzalez A (2006). 
Identification  and evaluation of Peruvian plants used to treat malaria 
and leishmaniasis. J. Ethnopharmacol. 106(3): 390-402. 
Dr. Ahmed T (2004). Medicinal Herbs and products, page no xxi and 
xxii; a printed version of herbal medicines from online drug 
information system: www.druginfosys.com.  
Rehman AU, Choudhary MI, Thomsen WJ (1991). In: (eds.) Manual of 
Bioassay Techniques for Natural Product Research, Harward 
Academic Press, Amsterdam, p. 17. 
Sezik E, Silada EY, Tabata M, Honda G, Takaishi Y, Fujita T, Tanaka T, 
Takeda Y  (1997). Traditional Medicine in Turkey VIII. Folk Medicine 
in East Anatolia; Erzurum, Erzincan, Agri, Kars, Igdir Provinces 
Ekrem. Econ. Bot. 51: 195-212. 
Shahina N (2005). Structure and functionality of the pigments isolated 
from Onosma hispidum (ratanjot) Terminalia catappa (jangli badam) 
and other tropical plant. Ph. D thesis, University of    Karachi, 
Karachi.  
Ozgen U, Houghton PJ, Ogundipe Y, Coskun M (2003). Antioxidant and 
antimicrobial activities of Onosma argenatum and Rubia peregrina. 
Fitoterapia, 74(7-8): 682-685  
Tosun A, Akkol EK, Bahadır O, Yeilada E (2008). Evaluation of anti-
inflammatory and antinociceptive activities of some Onosma L. 
species growing in Turkey. J. Ethnopharmacol. 120(3): 378-831.  
Ufuk O, Maksut CK, Cavit K, Hasan SK (2004). Naphthoquinones from 
the Roots of Onosma argentatum Hub. Mor. (Boraginaceae). Turk. J. 
Chem. 28: 451-454 
World Health Organization (1984). The leishmaniasis. Report of a WHO 
expert committee. Tech. Rep. Series WHO No 701, Geneva. 
 
 
 
 
 
 
 
 
 
